Levetiracetam Stadafarma (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which plays a crucial role in regulating neurotransmitter release. By modulating SV2A activity, the drug stabilises neuronal firing and diminishes excessive excitability, thereby lowering the likelihood of seizure initiation and spread.

The dosage of Levetiracetam Stadafarma is individualized and determined by the prescribing healthcare professional based on the patient’s age, weight, renal function, and seizure type. Patients should follow the dose prescribed by their clinician and not adjust it without medical advice.

Safety data for levetiracetam in pregnancy and lactation are limited. The medication should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Levetiracetam offers a distinct mechanism of action by targeting SV2A, which differs from sodium‑channel blockers such as carbamazepine or phenytoin. It generally has fewer drug‑enzyme interactions, a favorable pharmacokinetic profile, and is often well tolerated, making it a useful alternative or adjunct in patients who experience side effects with other agents.

Store Levetiracetam Stadafarma at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and excessive heat. Do not use if the packaging is damaged or if the tablets show signs of degradation.

Levetiracetam Stadafarma is taken orally, usually with or without food, as directed by the prescribing clinician. The tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, blood dyscrasias, and significant mood changes including suicidal thoughts or severe depression. Patients should seek immediate medical attention if they experience rash, fever, unexplained bruising, or any sudden change in mood or behavior.

Levetiracetam Stadafarma is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric disorders, or those taking medications that may significantly alter its plasma levels without appropriate monitoring.